The Live Conference on Rare Diseases and Orphan Drugs, scheduled for September 14–15, 2026, is a premier international event dedicated to advancing research, innovation, and collaboration in the field of rare diseases and orphan therapeutics. The conference aims to bring together leading scientists, clinicians, healthcare professionals, pharmaceutical experts, researchers, academicians, policy makers, and patient advocacy groups from across the globe.
Rare diseases continue to present significant challenges in diagnosis, treatment, and patient management due to limited awareness, research, and therapeutic options. This conference provides a unique platform to discuss the latest scientific discoveries, emerging technologies, clinical advancements, regulatory developments, and innovative drug development strategies focused on improving the lives of patients affected by rare disorders.
The program will feature keynote lectures, oral and poster presentations, panel discussions, workshops, and networking opportunities covering a wide range of topics related to genetics, precision medicine, biomarker discovery, clinical trials, orphan drug development, regulatory affairs, patient care, and future therapeutic approaches.
The conference is designed to encourage interdisciplinary collaboration, knowledge exchange, and global partnerships that can accelerate progress in rare disease research and orphan drug innovation. Participants will gain valuable insights into current trends, challenges, and opportunities shaping the future of rare disease diagnosis and treatment.
Join us to connect with international experts, share groundbreaking research, and contribute to advancing healthcare solutions for rare disease patients worldwide.
Dear Colleagues,
Welcome to the Live Conference on Rare Diseases and Orphan Drugs, taking place on September 14–15, 2026. We are delighted to bring together distinguished researchers, healthcare professionals, clinicians, pharmaceutical experts, academicians, industry leaders, and patient advocates from around the world to discuss the latest advancements and challenges in the field of rare diseases and orphan drug development.
This conference serves as a global platform for sharing innovative research, emerging therapies, clinical experiences, and collaborative approaches aimed at improving diagnosis, treatment, and patient care for rare diseases. Through engaging keynote presentations, scientific sessions, and interactive discussions, participants will have the opportunity to exchange knowledge, foster partnerships, and explore future directions in rare disease research and orphan therapeutics.
We sincerely thank all speakers, delegates, sponsors, and organizing committee members for their valuable contributions and support. We hope this conference will inspire meaningful discussions, encourage new collaborations, and accelerate progress toward better healthcare solutions for patients affected by rare diseases worldwide.
We look forward to your participation and wish you a productive and enriching conference experience.
With Regards,
Organizing Committee
RDOD 2026
| 08:30 - 09:00 | Registrations |
| 09:00 - 09:20 | Inaugural Ceremony |
| 09:20 - 10:20 | Keynote Presentations |
| 10:20 - 10:30 | Group Photography |
| 10:30 - 10:50 | Coffee Break & Networking |
| 10:50 - 12:50 | Oral Presentations |
| 12:50 - 13:40 | Lunch Break & Networking |
| 13:40 - 15:40 | Oral Presentations |
| 15:40 - 16:00 | Coffee Break & Networking |
| 16:00 - 16:30 | Exhibitor/Sponsor Presentations |
| 16:30 - 17:10 | Symposiums/Workshops/Posters/YRF |
| 17:10 - 17:30 | Certificates Distribution |
| 08:30 - 09:00 | Registrations |
| 09:00 - 09:20 | Session Introduction |
| 09:20 - 10:20 | Keynote Presentations |
| 10:20 - 10:30 | Group Photography |
| 10:30 - 10:50 | Coffee Break & Networking |
| 10:50 - 12:50 | Oral Presentations |
| 12:50 - 13:40 | Lunch Break & Networking |
| 13:40 - 15:40 | Oral Presentations |
| 15:40 - 16:00 | Coffee Break & Networking |
| 16:00 - 16:30 | Exhibitor/Sponsor Presentations |
| 16:30 - 17:10 | Symposiums/Workshops/Posters/YRF |
| 17:10 - 17:30 | Certificates Distribution |
Join us at the Live Conference on Rare Diseases and Orphan Drugs, taking place on September 14–15, 2026, to explore the latest advancements and innovations in rare disease research and orphan drug development. This international conference provides an excellent platform for researchers, clinicians, healthcare professionals, pharmaceutical experts, academicians, industry leaders, and patient advocates to connect, collaborate, and exchange knowledge.
Key Reasons to Attend
a. Gain insights into the latest advancements in rare disease diagnosis, treatment, and patient care.
b. Learn about emerging trends in orphan drug discovery, development, and regulatory strategies.
c. Hear from internationally recognized experts through keynote presentations and scientific sessions.
d. Present your research findings and receive valuable feedback from global professionals and researchers.
e. Explore innovative technologies, precision medicine approaches, and novel therapeutic solutions.
f. Connect and network with leading scientists, healthcare providers, biotech companies, and pharmaceutical organizations.
g. Discover opportunities for collaborations, partnerships, and future research projects.
h. Enhance your professional knowledge through interactive discussions, workshops, and panel sessions.
i. Stay updated on current challenges, regulatory policies, and future opportunities in rare disease management.
j. Contribute to meaningful discussions aimed at improving healthcare outcomes for patients affected by rare diseases worldwide.
Be part of this important global gathering on September 14–15, 2026, and contribute to shaping the future of rare disease research and orphan therapeutics.
The Live Conference on Rare Diseases and Orphan Drugs, scheduled for September 14–15, 2026, welcomes participants from academic institutions, healthcare organizations, research centers, pharmaceutical industries, biotechnology companies, regulatory agencies, and patient advocacy groups from around the world.
This conference is designed for:
i. Researchers and Scientists
ii. Physicians and Clinicians
iii. Healthcare Professionals
iv. Geneticists and Molecular Biologists
v. Pharmaceutical and Biotechnology Professionals
vi. Orphan Drug Developers and Manufacturers
vii. Clinical Research Organizations (CROs)
viii. Regulatory and Policy Experts
ix. Academicians and University Faculty
x. Postgraduate Students and Research Scholars
xi. Public Health Professionals
xii. Medical Device and Diagnostic Experts
xiii. Patient Advocacy Organizations
xiv. Investors and Industry Representatives
xv. Healthcare Consultants and Innovators
Participants will have the opportunity to engage with global experts, present research, discuss emerging trends, and explore innovative approaches in rare disease diagnosis, treatment, and orphan drug development.
Whether you are an experienced professional, researcher, healthcare provider, or student, this conference provides an ideal platform to expand your knowledge, build professional networks, and contribute to advancements in rare disease healthcare and therapeutics.
Your abstract has been submitted successfully. We will review and get back to you shortly.
Thank you for your interest. Click on the below link to Download Brochure.
Thank you for your interest. Click on the below link to Download Sponsors / Exhibitors.
